SCHEMBL2333877

SCHEMBL2333877

CCC(=O)Oc1ccc(CCl)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
ESR1 P03372 2/20 0.59
HIF1A Q16665 2/20 0.59
RECQL P46063 1/20 0.59
ELANE P08246 2/20 0.54
ACHE P22303 2/20 0.46
MAPT P10636 3/20 0.46
LMNA P02545 2/20 0.46
HTT P42858 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HSD17B10 Q99714 2/20 0.46
RAB9A P51151 3/20 0.44
ALOX15 P16050 1/20 0.44
NPC1 O15118 2/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL312147 0.85 KMT2A (0.76) KMT2ASMN1; SMN2ESR1HIF1ARECQL
SCHEMBL1512672 0.84 KMT2A (0.63) KMT2ASMN1; SMN2ESR1HIF1ARECQL
SCHEMBL11445596 0.83 KMT2A (0.73) KMT2ASMN1; SMN2ESR1HIF1ARECQL
SCHEMBL27902979 0.82 KMT2A (0.61) KMT2ASMN1; SMN2ESR1HIF1ARECQL
SCHEMBL170186 0.82 KMT2A (0.61) KMT2ASMN1; SMN2ESR1HIF1ARECQL
SCHEMBL27324289 0.81 KMT2A (0.59) KMT2ASMN1; SMN2ESR1HIF1ARECQL
SCHEMBL480087 0.81 KMT2A (0.59) KMT2ASMN1; SMN2ESR1HIF1ARECQL
SCHEMBL20593516 0.81 THRB (0.64) KMT2ASMN1; SMN2ESR1HIF1ARECQL
SCHEMBL197418 0.80 KMT2A (0.63) KMT2ASMN1; SMN2ESR1HIF1ARECQL
SCHEMBL9799923 0.80 KMT2A (0.63) KMT2ASMN1; SMN2ESR1HIF1ARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100376242-C 2-aryl-propionic acid and medicine composition containing same DOMPAY CO LTD (IT) 2008-03-26 CN claimed
CN-1612729-A 2-Aryl-propionic acids and pharmaceutical compositions containing them DOMPAY CO LTD (IT) 2005-05-04 CN claimed
WO-2021005167-A1 LIGANDS FOR CAPTURING MICROVESICLES AND USES THEREOF UNIVERSITÉ DE BORDEAUX (FR) 2021-01-14 WO disclosed
CN-106349051-A Preparation method of methyl 2-(4-chloromethylphenyl)propionate 宁波博撷化学科技有限公司 2017-01-25 CN disclosed
EP-1940818-B1 AMINOACID DERIVATIVES CONTAINING A DISULFANYL GROUP IN THE FORM OF MIXED DISULFANYL AND AMINOPEPTIDASE N INHIBITORS PHARMALEADS (FR) 2011-08-24 EP disclosed
EP-1940818-A1 AMINOACID DERIVATIVES CONTAINING A DISULFANYL GROUP IN THE FORM OF MIXED DISULFANYL AND AMINOPEPTIDASE N INHIBITORS Pharmaleads (FR) 2008-07-09 EP disclosed
CN-100376242-C 2-aryl-propionic acid and medicine composition containing same DOMPAY CO LTD (IT) 2008-03-26 CN disclosed
WO-2007048787-A1 AMINOACID DERIVATIVES CONTAINING A DISULFANYL GROUP IN THE FORM OF MIXED DISULFANYL AND AMINOPEPTIDASE N INHIBITORS PHARMALEADS (FR) 2007-05-03 WO disclosed
CN-1612729-A 2-Aryl-propionic acids and pharmaceutical compositions containing them DOMPAY CO LTD (IT) 2005-05-04 CN disclosed
EP-1150673-A4 MONO-ACYLOXY ARALKYL NEUROMUSCULAR RELAXANTS NEWLAXANT L L C (US) 2002-04-24 EP disclosed
CN-1338934-A Mono-acyloxy aralkyl neuronuscular relaxants NEWLAXANT L L C (US) 2002-03-06 CN disclosed
EP-1150673-A1 MONO-ACYLOXY ARALKYL NEUROMUSCULAR RELAXANTS Newlaxant, L.L.C. (US) 2001-11-07 EP disclosed
WO-2000044377-A1 MONO-ACYLOXY ARALKYL NEUROMUSCULAR RELAXANTS NEWLAXANT, L.L.C. (US) 2000-08-03 WO disclosed